HPLE
Live / Registered — Registered (as of 06 Oct 2020)
What this means for you
Registered since 06 Oct 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use was filed 05 Oct 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 87307478
- Registration number
- 6169629
- Mark type
- Word mark
- Filed
- 19 Jan 2017
- Published for opposition
- 27 Jun 2017
- Registered
- 06 Oct 2020
- Next maintenance filing
- §8 declaration of use, filed 05 Oct 2026 — awaiting the USPTO's acceptance
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 001 — Chemicals: Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; Chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry
- Class 042 — Scientific and technological services: Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines
Owner
- Pfanstiehl, Inc., Waukegan, IL, US
- Pfanstiehl, Inc., Waukegan, IL, US
- Pfanstiehl, Inc., Waukegan, IL, US
Prosecution history
- 05 Oct 2026 — TEAS SECTION 8 & 15 RECEIVED
- 06 Oct 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
- 01 Sept 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Aug 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Aug 2020 — USE AMENDMENT FILED
- 23 Aug 2020 — TEAS STATEMENT OF USE RECEIVED
- 03 Mar 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Mar 2020 — SOU EXTENSION 5 GRANTED
- 19 Feb 2020 — SOU EXTENSION 5 FILED
- 02 Mar 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Feb 2020 — SOU TEAS EXTENSION RECEIVED
- 23 Aug 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED